vai alle Pubblicazioni
Publications prior to 2004
Elenco
Pubblicazioni per extenso Ottobre 2013
1.
Beadling C, Patterson J, Justusson E, Nelson D,
Pantaleo MA, Hornick JL, Chacón M, Corless CL, Heinrich MC.
Gene expression of the IGF pathway family
distinguishes subsets of gastrointestinal stromal tumors wild type
for KIT and PDGFRA.
Cancer Med.
2013 Feb;2(1):21-31. doi: 10.1002/cam4.57. Epub 2013 Feb 3. PMID: 24133624 [PubMed - in
process]
2.
Nannini M, Biasco G, Astolfi A, Urbini
M, Pantaleo MA.Insulin-like Growth Factor (IGF) system and
gastrointestinal stromal tumours (GIST): present and future.
Histol Histopathol.
2013 Oct 16. [Epub ahead of print] Review. PMID:
24129766[PubMed]
.
3.
Brandi G, Derenzini E, Falcone A, Masi G, Loupakis F,
Pietrabissa A, Pinna AD, Ercolani G, Pantaleo MA, Di
Girolamo S, Grazi GL, de Rosa F, Biasco G. Adjuvant systemic
chemotherapy after putative curative resection of colorectal liver
and lung metastases.
Clin Colorectal Cancer.
2013 Sep;12(3):188-94. doi:
10.1016/j.clcc.2013.04.002. Epub 2013 Jun 14.PMID:23773458[PubMed - in
process]
4.
Nannini M, Biasco G, Astolfi A,
Pantaleo MA.
An overview on molecular biology of KIT/PDGFRA wild
type (WT) gastrointestinal stromal tumours
(GIST).
J Med
Genet. 2013 Oct;50(10):653-61. doi: 10.1136/jmedgenet-2013-101695.
Epub
2013 Jul 5. PMID: 23833252 [PubMed -
in process]
5.
Nannini M, Pantaleo MA, Biasco G.
Role of molecular analysis in the adjuvant treatment of
gastrointestinal stromal tumours: it is time to define
it.
World J Gastroenterol. 2013 Apr
28;19(16):2583-6. doi: 10.3748/wjg.v19.i16.2583.
PMID:23674864
[PubMed - in process]
6.
Pantaleo MA, Astolfi A, Urbini M, Nannini M,
Paterini P, Indio V, Saponara M, Formica S, Ceccarelli C, Casadio
R, Rossi G, Bertolini F, Santini D, Pirini MG, Fiorentino M, Basso
U, Biasco G. Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of
the succinate dehydrogenase complex in KIT/PDGFRA wild-type
GIST.
Eur J Hum Genet. 2014;
22(1):32-9.doi: 10.1038/ejhg.2013.80. [Epub ahead of print.
PMID:
23612575[PubMed ]
7.
Pallotti MC, Pantaleo MA, Nannini M, Centofanti
F, Fabbrizio B, Montanari M, Baraldi O, Saponara M, Lolli C,
Mandrioli A, Biasco G, Prandini R. Development of a Nephrotic
Syndrome in a Patient with Gastrointestinal Stromal Tumor during a
Long-Time Treatment with Sunitinib. Case Rep
Oncol. 2012
Sep; 5(3):651-6. doi: 10.1159/000345946.
PMID:23275781[PubMed]
8.
Nannini M, Astolfi A, Paterini P,
Urbini M, Santini D, Catena F, Indio V, Casadio R, Pinna AD, Biasco
G, Pantaleo MA. Expression of IGF-1 receptor in KIT/PDGF
receptor-α
wild-type gastrointestinal stromal tumors with
succinate dehydrogenase complex dysfunction. Future Oncol. 2013
Jan;9(1):121-6. doi: 10.2217/fon.12.170.
PMID:23252569
9.
Catena F, Di
Battista M, Ansaloni L,
Pantaleo M, Fusaroli P, Di Scioscio V, Santini D,
Nannini M, Saponara M, Ponti G, Persiani R, Delrio P, Coccolini F,
Di Saverio S, Biasco G, Lazzareschi D, Pinna A.Microscopic margins of resection
influence primary gastrointestinal stromal tumor
servival.
Onkologie. 2012;35(11):645-8. doi: 10.1159/000343585.
Epub 2012 Oct 16
10.
Angelini S*, Pantaleo
MA*, Ravegnini G, Zenesini C, Cavrini G, Nannini M, Fumagalli
E, Palassini E, Saponara M, Di Battista M, Casali PG, Hrelia P,
Cantelli-Forti G, Biasco G.Polymorphisms in OCTN1 and OCTN2
transporters genes are associated with prolonged time to
progression in unresectable gastrointestinal stromal tumours
treated with imatinib therapy.
Pharmacol Res. 2012 Nov 2.
doi:pii: S1043-6618(12)00202-2. 10.1016/j.phrs.2012.10.015. [Epub
ahead of print]
*The authors contributed equally to the
work
11.
Nannini M, Pantaleo MA, Catena F,
Romano S, Tondo S, Pirini MG, Lolli C, Maleddu A, Mandrioli A,
Gatto L, Saponara M, Pallotti MC, Dei Tos AP, Pinna AD, Biasco G.
Surgical second-look in high risk gastrointestinal stromal tumor of
small intestine: A case report.
Int J Surg Case Rep. 2012 Sep 19;4(1):7-10. doi:
10.1016/j.ijscr.2012.07.019. [Epub ahead of
print]
12.
Bertucci F, Finetti P, Ostrowski J, Kim WK,
Kim H, Pantaleo
MA, Astolfi A, Polkowski M, Birnbaum D.Genomic Grade Index
predicts postoperative clinical outcome of GIST.
Br J Cancer. 2012 Oct 9;107(8):1433-41. doi:
10.1038/bjc.2012.390. Epub 2012 Aug 28
13.
Nannini M, Pantaleo MA, Maleddu A,
Saponara M, Mandrioli A, Lolli C, Pallotti MC, Gatto L, Santini D,
Paterini P, DI Scioscio V, Catena F, Fusaroli P, Pinna AD, Tos AP,
Biasco G. Duration of adjuvant treatment following radical
resection of metastases from gastrointestinal stromal
tumours.
Oncol Lett. 2012 Mar;3(3):677-681. Epub 2011 Dec
23
14.
Pantaleo MA, Mandrioli A,
Saponara M, Nannini M, Erente G, Lolli C, Biasco G. Development of
coronary artery stenosis in a patient with metastatic renal cell
carcinoma treated with sorafenib.
BMC Cancer. 2012 Jun 11;12:231. PMID:22687270[PubMed - indexed for
MEDLINE]
15.
Saponara M, Pantaleo MA, Nannini M,
Biasco G. Chronic therapy in gastrointestinal stromal tumours
(GISTs): the big gap between theory and
practice.
Target Oncol. 2012 May 17. [Epub ahead of print] PubMed
PMID: 22592950.
16.
Pantaleo MA, Nannini M,
Saponara M, Gnocchi C, Di Scioscio V, Lolli C, Catena F, Astolfi A,
Di Battista M, Biasco G; GIST Study Group, University of Bologna,
Bologna, Italy. Impressive long-term disease stabilization by
nilotinib in two pretreated patients with KIT/PDGFRA wild-type
metastatic gastrointestinal stromal
tumours.
Anticancer Drugs. 2012 Jun;23(5):567-72. PubMed PMID:
22430048.
17.
Lolli C, Pantaleo MA, Nannini M,
Saponara M, Pallotti MC, Scioscio VD, Barbieri E, Mandrioli A,
Biasco G.
Successful radiotherapy for local control of progressively
increasing metastasis of gastrointestinal stromal
tumor.
Rare Tumors. 2011 Oct 21;3(4):e49. Epub 2011 Oct 26. PubMed
PMID: 22355504; PubMed Central PMCID: PMC3282454.
18.
Pantaleo
MA,
Astolfi A, Nannini M, Ceccarelli C, Formica S, Santini D, Heinrich
MC, Corless C, Dei Tos AP, Paterini P, Catena F, Maleddu A,
Saponara M, Di
Battista M, Biasco G. Differential expression of neural markers in
KIT and PDGFRA wild-type gastrointestinal stromal
tumours.
Histopathology. 2011 Dec;59(6):1071-80. doi:
10.1111/j.1365-2559.2011.04071.x. PubMed PMID: 22175887.
19.
Fuccio C, Musto A, Cambioli S, Castellucci
P, Pantaleo MA, Nanni
C, Montini GC, Campana D, Tomassetti P, Bellan E, Massaro A,
Grassetto G, Rubello D, Fanti S. When should F-18 FDG PET/CT be
used instead of 68Ga-DOTA-peptides to investigate metastatic
neuroendocrine tumors?
Clin Nucl Med. 2011 Dec;36(12):1109-11. PubMed PMID:
22064082.
20.
Pantaleo MA, Nannini M,
Astolfi A, Biasco G; GIST Study Group Bologna. A distinct
pediatric-type gastrointestinal stromal tumor in adults: potential
role of succinate
dehydrogenase subunit A mutations.
Am J Surg Pathol. 2011 Nov;35(11):1750-2.
PubMed PMID: 21997697.
21.
Nannini M, Pantaleo MA, Biasco G. The
follow-up after radical surgery of colorectal cancer: is it time
for a "tailored" strategy?
Clin Colorectal Cancer. 2011 Jun;10(2):81-4. Epub
2011 Apr 22. PubMed PMID: 21859558.
22.
Di Scioscio V, Greco L, Pallotti MC, Pantaleo MA, Maleddu A,
Nannini M, Bazzocchi A, Di Battista M, Mandrioli A,
Lolli C, Saponara M, Giorgio G, Biasco G, Zompatori M.
Three cases of bone metastases in patients with
gastrointestinal
stromal tumors.
Rare Tumors. 2011 Apr 4;3(2):e17. PubMed PMID: 21769316;
PubMed Central PMCID: PMC3132121.
23.
Maleddu A, Pantaleo MA, Nannini M,
Biasco G. The role of mutational analysis of KIT and PDGFRA in
gastrointestinal stromal tumors in a clinical
setting.
J Transl Med. 2011 May 23;9:75. doi:
10.1186/1479-5876-9-75. Review. PubMed PMID: 21605429; PubMed
Central PMCID: PMC3224648.
24.
Pantaleo
MA,
Astolfi A, Indio V, Moore R, Thiessen N, Heinrich MC, Gnocchi C,
Santini D, Catena F, Formica S, Martelli PL, Casadio R, Pession A,
Biasco G. SDHA loss-of-function mutations in KIT-PDGFRA wild-type
gastrointestinal stromal tumors identified by massively parallel
sequencing.
J Natl Cancer Inst. 2011 Jun 22;103(12):983-7. doi:
10.1093/jnci/djr130. Epub 2011 Apr 19. PubMed PMID:
21505157.
25.
Nannini M, Biasco G, Maleddu A, Pantaleo MA. New molecular targets
beyond KIT and PDGFRA in gastrointestinal stromal tumors: present
and future.
Expert Opin Ther Targets. 2011 Jul;15(7):803-15. Epub 2011
Mar 9. Review. PubMed PMID: 21385119.
26.
Nannini M, Biasco G, Pallotti MC, Di
Battista M, Santini D, Paterini P, Maleddu A, Mandrioli A, Lolli C,
Saponara M, Di Scioscio V, Zompatori M, Catena F, Fusaroli P, Dei
Tos AP, Pantaleo MA.
Late
recurrences of gastrointestinal stromal tumours (GISTs) after 5
years of follow-up.
Med Oncol. 2012 Mar;29(1):144-50. Epub 2011 Jan
22. PubMed PMID: 21258878.
27.
Pantaleo MA, Nicoletti G,
Nanni C, Gnocchi C, Landuzzi L, Quarta C, Boschi S, Nannini M, Di
Battista M, Castellucci P, Fanti S, Lollini PL, Bellan E,
Castelli M, Rubello D,
Biasco G. Preclinical evaluation of KIT/PDGFRA and mTOR
inhibitors in
gastrointestinal stromal tumors using small animal FDG PET.
J
Exp Clin
Cancer Res. 2010 Dec
30;29:173. PubMed PMID: 21192792; PubMed Central PMCID:
PMC3022678.
28.
Nannini M, Biasco G, Di Scioscio V, Di
Battista M, Zompatori M, Catena F, Castellucci P, Paterini P, Dei
Tos AP, Stella F, Maleddu A, Pantaleo MA. Clinical,
radiological and biological features of lung metastases in
gastrointestinal stromal tumors (case
reports).
Oncol Rep. 2011 Jan;25(1):113-20. PubMed PMID:
21109965.
29.
1Pantaleo MA, Astolfi A,
Nannini M, Biasco G. The emerging role of insulin-like growth
factor 1 receptor (IGF1r) in gastrointestinal stromal tumors
(GISTs).
J Transl Med. 2010 Nov 15;8:117. PubMed PMID: 21078151;
PubMed Central PMCID: PMC2992499.
30.
Pantaleo
MA,
Di Battista M, La Rovere S, Astorino M, Catena F, Lolli C, Saponara
M, Maleddu A, Nannini M, Di Scioscio V, Santini D, Ceccarelli C,
Paterini P, Castellucci P, Astolfi A, Mandrioli A, Fusaroli P,
Tomassetti P, Pinna AD, Biasco G. Management of patients with
gastrointestinal stromal tumor in clinical practice in Italy: a
critical "event tree model" analysis of decision-making processes
and outcomes.
Tumori. 2010 Mar-Apr;96(2):219-28. PubMed
PMID: 20572577.
31.
Astolfi A, Nannini M, Pantaleo MA, Di Battista
M, Heinrich MC, Santini D, Catena F, Corless CL, Maleddu A,
Saponara M, Lolli C, Di Scioscio V, Formica S, Biasco G. A
molecular portrait of gastrointestinal stromal tumors: an
integrative analysis of gene expression profiling and
high-resolution genomic copy number.
Lab Invest. 2010 Sep;90(9):1285-94. Epub 2010 Jun
14. PubMed PMID: 20548289.
32.
Pantaleo MA, Mishani E,
Nanni C, Landuzzi L, Boschi S, Nicoletti G, Dissoki S, Paterini P,
Piccaluga PP, Lodi F, Lollini PL, Fanti S, Biasco G. Evaluation of
modified PEG-anilinoquinazoline derivatives as potential agents for
EGFR imaging in cancer
by small animal PET.
Mol Imaging Biol. 2010 Dec;12(6):616-25. PubMed PMID:
20379787; PubMed Central PMCID: PMC2978890.
33.
1Nannini M, Pantaleo MA, Paterini P,
Piazzi G, Ceccarelli C, La Rovere S, Maleddu A, Biasco G. Molecular
detection of epidermal growth factor receptor in colorectal cancer:
does it still make sense?
Colorectal Dis. 2011 May;13(5):542-8. doi:
10.1111/j.1463-1318.2010.02212.x. PubMed PMID: 20070321.
34.
Pantaleo
MA,
Nannini M, Di Battista M, Catena F, Biasco G. Combined treatment
strategies in gastrointestinal stromal tumors (GISTs) after
imatinib and sunitinib therapy.
Cancer Treat Rev. 2010 Feb;36(1):63-8. Epub 2009 Nov
14. Review. PubMed PMID: 19914780.
35.
Di Cicilia R, Castellucci P, Nannini
M, Balbi T, Zannetti G, Fanti S, Biasco G, Pantaleo MA. Unusual finding of
benign Abrikossoff tumor by F-18 FDG-PET mimicking melanoma
recurrence.
Clin Nucl Med. 2009 Oct;34(10):696-7. PubMed PMID:
19893405.
36.
Maleddu A, Pantaleo MA, Castellucci
P, Astorino M, Nanni C, Nannini M, Busato F, Di Battista M, Farsad
M, Lodi F, Boschi S, Fanti S, Biasco G. 11C-acetate PET for early prediction of
sunitinib response in metastatic renal cell carcinoma. Tumori. 2009
May-Jun;95(3):382-4. PubMed PMID: 19688982.
37.
Pantaleo MA, Astolfi A, Di
Battista M, Heinrich MC, Paterini P, Scotlandi K, Santini D, Catena F, Manara
MC, Nannini M, Maleddu A, Saponara M, Lolli C, Formica S, Biasco G.
Insulin-like growth factor 1 receptor expression in wild-type
GISTs: a potential novel therapeutic target.
Int J Cancer. 2009 Dec 15;125(12):2991-4. PubMed PMID:
19672856.
38.
Pantaleo
MA,
Nannini M, Fanti S, Boschi S, Lollini PL, Biasco G. Molecular
imaging of EGFR: it's time to go beyond receptor
expression.
J Nucl Med. 2009 Jul;50(7):1195-6; author reply 1196,
1197. Epub 2009 Jun 12. PubMed PMID: 19525453.
39.
Maleddu A, Pantaleo MA, Nannini M, Di
Battista M, Saponara M, Lolli C, Biasco G. Mechanisms of secondary
resistance to tyrosine kinase inhibitors in gastrointestinal
stromal tumours (Review).
Oncol Rep. 2009 Jun;21(6):1359-66. Review. PubMed PMID:
19424610.
40.
Saponara M, Di Battista M, Lolli C, Pantaleo MA, Azzaroli F,
Santini D, Di Scioscio V, Catena F, Astorino M, Maleddu A, Biasco
G. Severe esophagitis in a patient with gastrointestinal stromal
tumor treated with imatinib.
Endoscopy. 2009;41 Suppl 2:E67-8. Epub 2009 Mar 24. PubMed
PMID: 19319786.
41.
Biasco G, Velo D, Angriman I, Astorino
M, Baldan A, Baseggio M, Basso U, Battaglia G, Bertin M, Bertorelle
R, Bocus P, Brosolo P, Bulzacchi A, Cannizzaro R, Da Dalt GF, Di Battista
M, Errante D, Fedrigo M, Frustaci S, Lionetti I, Massani M,
Mencarelli R, Montesco MC, Norberto L, Pantaleo MA, Pasquali C,
Pastorelli D, Rossi CR, Ruffolo C, Salvagno L, Saponara MS,
Vittadello F, Zaccaria F, Zovato S, Farinati F; Section of Oncology
of the Italian Society of Gastroenterology; Interdisciplinary GIST
Group-G.I.GIST, Veneto Institute of Oncology IOV-IRCCS Azienda
Ospedale, University of Padua; GIST Study Group, Bologna
University. Gastrointestinal stromal tumors: report of an audit
and review of the literature.
Eur J Cancer Prev. 2009 Apr;18(2):106-16.
Review. PubMed PMID: 19337057.
42.
Nannini M, Pantaleo MA, Maleddu A,
Al-Nahhas A, Rubello D, Fanti S, Biasco G. The Response Evaluation
Criteria in Solid Tumors: until when?
Nucl Med Commun. 2009 Mar;30(3):185-7. PubMed PMID:
19262278.
43.
Pantaleo
MA,
Landuzzi L, Nicoletti G, Nanni C, Boschi S, Piazzi G, Santini D, Di
Battista M, Castellucci P, Lodi F, Fanti S, Lollini PL, Biasco G.
Advances in
preclinical therapeutics development using small animal imaging and
molecular analyses: the gastrointestinal stromal tumors
model.
Clin Exp Med. 2009 Sep;9(3):199-205. Epub 2009 Feb 19.
PubMed PMID: 19225718; PubMed Central PMCID: PMC2709232.
44.
Nannini M, Nobili E, Di Cicilia R, Brandi G,
Maleddu A, Pantaleo MA,
Biasco G. To widen the setting of cancer patients who could benefit
from metronomic capecitabine.
Cancer Chemother Pharmacol. 2009 Jun;64(1):189-93.
Epub 2009 Jan 17. PubMed PMID: 19151974.
45.
Strillacci A, Griffoni C,
Sansone P, Paterini P, Piazzi G, Lazzarini G, Spisni E, Pantaleo MA, Biasco G,
Tomasi V. MiR-101 downregulation is involved in cyclooxygenase-2
overexpression in human colon cancer cells.
Exp Cell Res. 2009 May 1;315(8):1439-47. Epub 2008 Dec
24. PubMed PMID: 19133256.
46.
Nannini M, Pantaleo MA, Maleddu A,
Astolfi A, Formica S, Biasco G. Gene expression profiling in
colorectal cancer using microarray technologies: results and
perspectives.
Cancer Treat Rev. 2009 May;35(3):201-9. Epub 2008 Dec
9. Review. PubMed PMID: 19081199.
47.
Pantaleo MA, Nannini M,
Maleddu A, Fanti S, Nanni C, Boschi S, Lodi F, Nicoletti G,
Landuzzi L, Lollini PL, Biasco. Experimental results
and related clinical implications of PET detection of epidermal
growth factor receptor (EGFr) in cancer.
Ann Oncol. 2009 Feb;20(2):213-26. Epub 2008 Oct
7. Review. PubMed PMID: 18842614.
48.
Pantaleo MA, Astolfi A,
Nannini M, Paterini P, Piazzi G, Ercolani G, Brandi G, Martinelli
G, Pession A, Pinna AD, Biasco G. Gene expression profiling of
liver metastases from colorectal cancer as potential basis for
treatment choice.
Br J Cancer. 2008 Nov 18;99(10):1729-34. Epub 2008 Sep 30.
PubMed PMID: 18827815; PubMed Central PMCID: PMC2584956.
49.
Brandi G, Nannini M, Pantaleo MA, Fanello S,
Farsad M, Fanti S, Ercolani G, Maleddu A, Di Battista M, Biasco G.
Molecular imaging suggests efficacy of bevacizumab beyond the
second line in advanced colorectal cancer patients.
Chemotherapy. 2008;54(6):421-4. Epub 2008 Sep 29. PubMed PMID:
18824847.
50.
Pantaleo MA, Nannini M,
Lopci E, Castellucci P, Maleddu A, Lodi F, Nanni C, Allegri V,
Astorino M, Brandi G, Di Battista M, Boschi S, Fanti S, Biasco G.
Molecular imaging and targeted therapies in oncology: new concepts
in treatment response assessment. a collection of
cases.
Int J Oncol. 2008
Sep;33(3):443-52. PubMed PMID: 18695872.
51.
Lelli G, Cataldo S,
Carandina I, Urbini B, Bonetti F, Marzola M, Biasco G, Pantaleo MA, Brandes A,
Calandri C, Ravaioli E, Nanni O, Boni C, Banzi C, Negri F, Panetta
A, DI Fabio F, Turci D. The role of cetuximab in pre-treated
refractory patients with metastatic colorectal cancer: outcome
study in clinical
practice.
J Chemother. 2008 Jun;20(3):374-9. PubMed PMID:
18606595.
52.
Pantaleo
MA,
Fanti S, Nannini M, Boschi S, Nanni C, Maleddu A, Rubello D, Biasco
G. What oncologists need and require from nuclear
medicine.
Eur J Nucl Med Mol Imaging. 2008
Oct;35(10):1761-5. PubMed PMID: 18509632.
53.
Catena F, Di Battista M, Fusaroli P,
Ansaloni L, Di Scioscio V, Santini D, Pantaleo M, Biasco G,
Caletti G, Pinna A. Laparoscopic treatment of gastric GIST: report
of 21 cases and literature's review.
J Gastrointest Surg. 2008 Mar;12(3):561-8. Review.
PMID:18040747[PubMed - indexed for
MEDLINE]
54.
Brandi G, Pantaleo MA, Biasco G,
Paterini P. Activated NF-kB in colorectal cancer: predictive or
prognostic factor?
J Clin Oncol. 2008 Mar 10;26(8):1388-9; author reply
1389-90. PubMed PMID: 18323566.
55.
Pantaleo MA, Di Battista
M, Catena F, Astorino M, Saponara M, Di Scioscio V, Santini D, Piazzi G,
Castellucci P, Brandi G, Biasco G. Surgical debulking of
gastrointestinal stromal tumors: is it a reasonable option after
second-line treatment with sunitinib?
J Cancer Res Clin Oncol. 2008 May;134(5):625-30. Epub 2008
Jan 17. PubMed PMID: 18202855.
56.
Pantaleo
MA,
Nannini M, Maleddu A, Fanti S, Ambrosini V, Nanni C, Boschi S,
Biasco G. Conventional and novel PET tracers for imaging in
oncology in the era of molecular therapy.
Cancer Treat Rev. 2008 Apr;34(2):103-21. Epub 2007 Dec
4. Review. PubMed PMID: 18055120.
57.
Pantaleo
MA,
Saponara M, Nannini M, Biasco G. Targeted therapies in solid
tumours: results and promises.
Minerva Med. 2007 Oct;98(5):603-23. Review. English,
Italian. PubMed PMID: 18043567.
58.
Pantaleo
MA,
Fanti S, Lollini PL, Boschi S, Biasco G. PET detection of epidermal
growth factor receptor in colorectal cancer: a real predictor of
response to cetuximab treatment?
Eur J Nucl Med Mol Imaging. 2007 Sep;34(9):1510-1. Epub
2007 Apr 20. PubMed PMID: 17447062.
59.
Biasco G, Nobili E, Calabrese C, Sassatelli
R, Camellini L, Pantaleo
MA, Bertoni G, De Vivo A, Ponz De Leon M, Poggioli G, Bedogni
G, Venesio T, Varesco L, Risio M, Di Febo G, Brandi G. Impact of
surgery on the development of duodenal cancer in patients with
familial adenomatous polyposis.
Dis Colon Rectum. 2006 Dec;49(12):1860-6. PubMed PMID:
17103055.
60.
Piazzi G, Paterini P, Ceccarelli C, Pantaleo MA, Biasco G.
Molecular determination of epidermal growth factor receptor in
normal and neoplastic colorectal mucosa.
Br J Cancer. 2006 Dec 4;95(11):1525-8. Epub 2006 Oct 31.
PubMed PMID: 17088913; PubMed Central PMCID: PMC2360732.
61.
Biasco G, Derenzini E, Grazi G, Ercolani G,
Ravaioli M, Pantaleo
MA, Brandi G. Treatment of hepatic metastases from colorectal
cancer: many doubts, some certainties.
Cancer Treat Rev. 2006 May;32(3):214-28. Epub 2006 Mar
20. Review. PubMed PMID: 16546323.
62.
Brandi G, Dabard J, Raibaud P, Di Battista
M, Bridonneau C, Pisi AM, Morselli Labate AM, Pantaleo MA, De Vivo A,
Biasco G. Intestinal microflora and digestive toxicity of irinotecan in
mice.
Clin Cancer Res. 2006 Feb 15;12(4):1299-307. PubMed PMID:
16489087.
63.
Pantaleo MA, Palassini E,
Labianca R, Biasco G. Targeted therapy in colorectal cancer: do we
know enough?
Dig Liver Dis. 2006 Feb;38(2):71-7. Epub 2005 Nov
10. Review. PubMed PMID: 16289975.
64.
Poggi R, Pantaleo MA, Benedetti G,
Biasco G. Cardiac metastasis of melanoma.
Melanoma Res. 2005 Aug;15(4):315-6. PubMed PMID:
16034311.
65.
Ceccarelli C, Piazzi G, Paterini P, Pantaleo MA, Taffurelli M,
Santini D, Martinelli GN, Biasco G. Concurrent EGFr and Cox-2
expression in colorectal cancer: proliferation impact and tumour
spreading.
Ann Oncol. 2005 May;16 Suppl 4:iv74-79. PubMed
PMID: 15923435.
66.
Biasco G, Pantaleo MA, Di Febo G,
Calabrese C, Brandi G. Risk of duodenal adenomas in familial
adenomatous polyposis to progress toward advanced neoplastic
disease.
J Clin Oncol. 2004 Sep
15;22(18):3835-6; author reply 3836-7. PubMed PMID:
15365086.
67.
Biasco G, Pantaleo MA, Di Febo G,
Calabrese C, Brandi G, Bulow S. Risk of duodenal cancer in patients
with familial adenomatous polyposis.
Gut. 2004 Oct;53(10):1547; author reply 1547. PubMed PMID:
15361514; PubMed Central PMCID: PMC1774216.
68.
Biasco G, Pantaleo MA, Nobili E,
Monti C. Spontaneous regression of a desmoid intraabdominal tumor
in a patient affected by familial adenomatous
polyposis.
Am J Gastroenterol. 2004
Aug;99(8):1621-2. PubMed PMID: 15307885.
69.
Brandi G, Pantaleo MA, Calabrese C,
Di Battista M, Poggi R, Bajetta E, Biasco G. Complete remission of
primary colon cancer in a metastatic patient treated with CPT-11
plus capecitabine.
Int J Colorectal Dis. 2004 Nov;19(6):599-602.
Epub 2004 Jun 8. PubMed PMID: 15185104.
70.
Brandi G, Calabrese C, Pantaleo MA, Morselli
Labate A, Di Febo G, Hakim R, De Vivo A, Di Marco MC, Biasco G.
Circadian variations of rectal cell proliferation in patients affected by
advanced colorectal cancer.
Cancer Lett. 2004 May 28;208(2):193-6. PubMed PMID:
15142678.
71.
Biasco G, Cenacchi G, Nobili E, Pantaleo MA, Calabrese C,
Di Febo G, Morselli Labate A, Miglioli M, Brandi G. Cell
proliferation and ultrastructural changes of the duodenal mucosa of
patients affected by familial adenomatous polyposis. Hum
Pathol. 2004 May;35(5):622-6. PubMed PMID: 15138938.
72.
Brandi G, Pantaleo MA, Galli C,
Falcone A, Antonuzzo A, Mordenti P, Di Marco MC, Biasco G.
Hypersensitivity reactions related to oxaliplatin (OHP).
Br J Cancer. 2003 Aug
4;89(3):477-81. PubMed PMID: 12888815; PubMed Central PMCID:
PMC2394366.
73.
Biasco G, Di Marco M, Pantaleo MA.
Chemoprevention of colorectal cancer.
Int J
Biol Markers. 2003 Jan-Mar;18(1):75-7. Review. PubMed PMID:
12699069.
74.
Biasco G, Pantaleo MA, Casadei S.
Treatment of brain metastases of malignant melanoma with
temozolomide.
N Engl J Med. 2001 Aug 23;345(8):621-2. PubMed
PMID:
11529230.
75.
Biasco G, Pantaleo M. Molecular
biology and the clinical management of patients with hereditary
colorectal cancer syndromes. Tumori. 2001 Jan-Feb;87(1 Suppl
1):S13-4.
PMID:11300011 [PubMed - indexed for
MEDLINE]
